DK2217210T3 - Retardtabletter med hydromorphon - Google Patents

Retardtabletter med hydromorphon

Info

Publication number: DK2217210T3
Authority: DK; Denmark
Prior art keywords: active agent; hydromorphone; layer; release; layer applied
Prior art date: 2007-11-09

Application number

DK08847385.5T

Other languages

English (en)

Inventor

Markus Reher

Marc Zingraff

Original Assignee

Acino Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-11-09

Filing date

2008-10-24

Publication date

2012-02-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39272211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2217210(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-10-24 Application filed by Acino Pharma Ag filed Critical Acino Pharma Ag

2012-02-13 Application granted granted Critical

2012-02-13 Publication of DK2217210T3 publication Critical patent/DK2217210T3/da

Links

WVLOADHCBXTIJK-YNHQPCIGSA-N hydromorphone Chemical compound O([C@H]1C(CC[C@H]23)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O WVLOADHCBXTIJK-YNHQPCIGSA-N 0.000 title abstract 3
229960001410 hydromorphone Drugs 0.000 title abstract 3
239000013543 active substance Substances 0.000 abstract 7
239000008188 pellet Substances 0.000 abstract 3
239000011248 coating agent Substances 0.000 abstract 1
238000000576 coating method Methods 0.000 abstract 1
239000000463 material Substances 0.000 abstract 1
230000000979 retarding effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Detergent Compositions (AREA)

DK08847385.5T 2007-11-09 2008-10-24 Retardtabletter med hydromorphon DK2217210T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07021788A EP2057984B1 (de)	2007-11-09	2007-11-09	Retardtabletten mit Hydromorphon
PCT/EP2008/009033 WO2009059701A2 (de)	2007-11-09	2008-10-24	Retardtabletten mit hydromorphon

Publications (1)

Publication Number	Publication Date
DK2217210T3 true DK2217210T3 (da)	2012-02-13

Family

ID=39272211

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK07021788.0T DK2057984T3 (da)	2007-11-09	2007-11-09	Retardtabletter med hydromorphon
DK08847385.5T DK2217210T3 (da)	2007-11-09	2008-10-24	Retardtabletter med hydromorphon

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK07021788.0T DK2057984T3 (da)	2007-11-09	2007-11-09	Retardtabletter med hydromorphon

Country Status (15)

Country	Link
US (1)	US20100247647A1 (da)
EP (3)	EP2057984B1 (da)
JP (1)	JP2011503017A (da)
AT (2)	ATE455538T1 (da)
AU (1)	AU2008324466A1 (da)
CA (1)	CA2704646C (da)
DE (1)	DE502007002695D1 (da)
DK (2)	DK2057984T3 (da)
ES (2)	ES2337935T3 (da)
HR (1)	HRP20100157T1 (da)
PL (1)	PL2057984T3 (da)
PT (1)	PT2057984E (da)
RS (1)	RS51313B (da)
SI (1)	SI2057984T1 (da)
WO (1)	WO2009059701A2 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU764453B2 (en)	1999-10-29	2003-08-21	Euro-Celtique S.A.	Controlled release hydrocodone formulations
US10179130B2 (en)	1999-10-29	2019-01-15	Purdue Pharma L.P.	Controlled release hydrocodone formulations
MXPA03003895A (es)	2000-10-30	2003-07-28	Euro Celtique Sa	Formulaciones de hidrocodona de liberacion controlada.
US20080069891A1 (en)	2006-09-15	2008-03-20	Cima Labs, Inc.	Abuse resistant drug formulation
US8445018B2 (en)	2006-09-15	2013-05-21	Cima Labs Inc.	Abuse resistant drug formulation
CA2784407A1 (en) *	2009-12-17	2011-07-14	Cima Labs Inc.	Abuse-resistant formulations
CA2798702A1 (en)	2010-05-11	2011-11-17	Cima Labs Inc.	Alcoholresistant metoprolol-containing extended-release oral dosage forms
EP2446882B8 (de) *	2010-10-28	2014-02-12	Acino Pharma AG	Arzneimittel mit dem Wirkstoff Hydromorphon mit verbesserter Lagerstabilität
EP2606879A1 (en)	2011-12-21	2013-06-26	Hexal AG	Multiple unit pellet tablet formulation comprising an opioid
CA2883077C (en) *	2012-09-03	2017-03-07	Daiichi Sankyo Company, Limited	Hydromorphone hydrochloride-containing oral sustained-release pharmaceutical composition
CA2881144A1 (en) *	2012-11-09	2014-05-09	Purdue Pharma	Pharmaceutical compositions comprising hydromorphone and naloxone
WO2015065547A1 (en)	2013-10-31	2015-05-07	Cima Labs Inc.	Immediate release abuse-deterrent granulated dosage forms
JP6696994B2 (ja)	2014-12-08	2020-05-20	クレシオ・バイオサイエンシズ・リミテッド	即放性乱用抑止性顆粒剤形
CN111432804A (zh)	2017-11-27	2020-07-17	帝斯曼知识产权资产管理有限公司	冻干的多微粒固体剂型
TW201943410A (zh)	2018-04-10	2019-11-16	荷蘭商帝斯曼知識產權資產管理有限公司	具有彈性結構之多顆粒固體劑型
US12589083B2 (en)	2019-05-07	2026-03-31	Clexio Biosciences Ltd.	Abuse-deterrent dosage forms containing esketamine
US11324707B2 (en)	2019-05-07	2022-05-10	Clexio Biosciences Ltd.	Abuse-deterrent dosage forms containing esketamine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3403329A1 (de) *	1984-02-01	1985-08-01	Horst Dr. 4019 Monheim Zerbe	Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe
GB8626098D0 (en) *	1986-10-31	1986-12-03	Euro Celtique Sa	Controlled release hydromorphone composition
US5266331A (en)	1991-11-27	1993-11-30	Euroceltique, S.A.	Controlled release oxycodone compositions
US5286493A (en)	1992-01-27	1994-02-15	Euroceltique, S.A.	Stabilized controlled release formulations having acrylic polymer coating
US5472712A (en) *	1991-12-24	1995-12-05	Euroceltique, S.A.	Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5273760A (en)	1991-12-24	1993-12-28	Euroceltigue, S.A.	Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5914131A (en) *	1994-07-07	1999-06-22	Alza Corporation	Hydromorphone therapy
US20020006438A1 (en) *	1998-09-25	2002-01-17	Benjamin Oshlack	Sustained release hydromorphone formulations exhibiting bimodal characteristics
DE19539361A1 (de) *	1995-10-23	1997-04-24	Basf Ag	Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
DE19927688A1 (de) *	1999-06-17	2000-12-21	Gruenenthal Gmbh	Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
JP2007520421A (ja) *	2003-06-26	2007-07-26	コリアリサーチインスティテュートオブケミカルテクノロジー	経口投与用放出制御型薬物送達システム
CA2874604A1 (en) *	2003-10-03	2005-04-21	Elite Laboratories Inc.	Extended release formulations of opioids and method of use thereof
US7670624B2 (en) *	2004-01-29	2010-03-02	Astella Pharma Inc.	Gastrointestinal-specific multiple drug release system
US10624858B2 (en) *	2004-08-23	2020-04-21	Intellipharmaceutics Corp	Controlled release composition using transition coating, and method of preparing same
US20070104789A1 (en) *	2005-11-04	2007-05-10	Donald Spector	Gastro-resistant and ethanol-resistant controlled-release formulations comprising hydromorphone
EP1993518A4 (en) *	2006-03-06	2012-12-12	Pozen Inc	DOSAGE FORMS FOR THE ADMINISTRATION OF MEDICINAL COMBINATIONS

2007
- 2007-11-09 PL PL07021788T patent/PL2057984T3/pl unknown
- 2007-11-09 AT AT07021788T patent/ATE455538T1/de active
- 2007-11-09 EP EP07021788A patent/EP2057984B1/de active Active
- 2007-11-09 DE DE502007002695T patent/DE502007002695D1/de active Active
- 2007-11-09 DK DK07021788.0T patent/DK2057984T3/da active
- 2007-11-09 SI SI200730176T patent/SI2057984T1/sl unknown
- 2007-11-09 PT PT07021788T patent/PT2057984E/pt unknown
- 2007-11-09 ES ES07021788T patent/ES2337935T3/es active Active
- 2007-11-09 RS RSP-2010/0084A patent/RS51313B/sr unknown
2008
- 2008-10-24 DK DK08847385.5T patent/DK2217210T3/da active
- 2008-10-24 WO PCT/EP2008/009033 patent/WO2009059701A2/de not_active Ceased
- 2008-10-24 CA CA2704646A patent/CA2704646C/en not_active Expired - Fee Related
- 2008-10-24 US US12/741,963 patent/US20100247647A1/en not_active Abandoned
- 2008-10-24 EP EP11191245A patent/EP2425822B1/de not_active Revoked
- 2008-10-24 ES ES08847385T patent/ES2374690T3/es active Active
- 2008-10-24 JP JP2010532471A patent/JP2011503017A/ja active Pending
- 2008-10-24 EP EP08847385A patent/EP2217210B1/de not_active Not-in-force
- 2008-10-24 AT AT08847385T patent/ATE536862T1/de active
- 2008-10-24 AU AU2008324466A patent/AU2008324466A1/en not_active Abandoned
2010
- 2010-03-18 HR HR20100157T patent/HRP20100157T1/hr unknown

Also Published As

Publication number	Publication date
EP2057984B1 (de)	2010-01-20
CA2704646A1 (en)	2009-05-14
CA2704646C (en)	2016-04-05
WO2009059701A3 (de)	2009-07-16
ATE536862T1 (de)	2011-12-15
PL2057984T3 (pl)	2010-05-31
AU2008324466A1 (en)	2009-05-14
ES2374690T3 (es)	2012-02-21
JP2011503017A (ja)	2011-01-27
EP2217210B1 (de)	2011-12-14
EP2425822A1 (de)	2012-03-07
EP2217210A2 (de)	2010-08-18
EP2425822B1 (de)	2012-12-19
US20100247647A1 (en)	2010-09-30
DE502007002695D1 (de)	2010-03-11
SI2057984T1 (sl)	2010-04-30
EP2057984A1 (de)	2009-05-13
PT2057984E (pt)	2010-03-10
HRP20100157T1 (hr)	2010-04-30
WO2009059701A2 (de)	2009-05-14
RS51313B (sr)	2010-12-31
DK2057984T3 (da)	2010-05-03
ATE455538T1 (de)	2010-02-15
ES2337935T3 (es)	2010-04-30

Publication	Publication Date	Title
DK2057984T3 (da)	2010-05-03	Retardtabletter med hydromorphon
DK1631251T3 (da)	2011-10-03	Tablet til forsinket frigørelse med defineret kernegeometri
PT2040755E (pt)	2011-07-08	Combinação de um inibidor de colinesterase e um composto com afinidade para o receptor 5-ht6
WO2008039291A3 (en)	2008-10-16	Dosage forms for tamper prone therapeutic agents
NO20053245L (no)	2005-10-04	Tabletter med modifisert frigjoring av bupropionhydroklorid.
NO20081733L (no)	2008-04-07	Kontrollert frigjorende farmasoytisk sammensetning av venlafaksinhydroklorid og fremgangsmate for dens fremstilling
AR099567A2 (es)	2016-08-03	Formulación de tableta revestida que comprende saxagliptina y método de preparación
BR112012024139A2 (pt)	2017-03-01	formulações farmacêuticas de camada dupla contendo agonistas e antagonistas de opióide.
WO2011060256A3 (en)	2012-03-15	Bilayer tablet formulations
WO2009025063A1 (ja)	2009-02-26	離型用シート
WO2012085657A3 (en)	2012-08-30	Tamper resistant solid oral dosage forms
NO20071175L (no)	2007-05-03	Sammensetning for langvarig medikamentfrigivning som viser et okende null-bestillende frigivningsmonster, fremgangsmate for fremstilling av en slik sammensetning
BRPI0719395C1 (pt)	2021-05-25	tablete revestido de filme
ES2723823T3 (es)	2019-09-02	Agente adhesivo con mezcla adhesiva de acrilato y copolímero de bloque de estireno
NO20052515L (no)	2005-05-25	Frigjoringskontrollerte sammensetninger
WO2011077239A3 (en)	2012-04-12	Slow release pharmaceutical compositions of iloperidone
TW200617943A (en)	2006-06-01	Layer jump on a multi-layer disc
EP1928431B8 (en)	2009-04-08	Controlled release pharmaceutical composition containing carvedilol
CL2007002054A1 (es)	2008-05-30	Sistema de proteccion para tuberias que comprende un recubrimiento que contiene copolimero de un polimero de hidrocarburo alquilo sustituido en combinacion con un polimero de dieno y una cinta para cubrir dicho recubrimiento, compuesto por un respald
AR061165A1 (es)	2008-08-06	Formulaciones de liberacion pulsada de fenilefrina y composiciones farmaceuticas
EP2486917A4 (en)	2016-04-13	COATING FILM AND GRANULES AND TABLETS THEREWITH
BR112013009347A2 (pt)	2016-07-26	composição, uso de um composto, método para produzir uma camada de liberação adesiva, agente de liberação e película de liberação.
CL2008003259A1 (es)	2010-02-05	Compuestos derivados de amida heterociclica; agente de control de fitoenfermedades que comprende a dichos compuestos; metodo de control de fitoenfermedades; y su uso de dichos compuestos.
WO2011090725A3 (en)	2011-11-17	Gastroretentive solid oral dosage forms with swellable hydrophilic polymer
WO2008065107A8 (en)	2008-09-12	Storage stable tablets based on benzimidazole derivatives coated with a gastro-resistant film